PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy
Clinical trial NCT04494009 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04494009
- Sponsor
- Asan Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2026-12-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.